GF Beilhack, YC Scheffold, IL Weissman, C … - Diabetes, 2003 - Am Diabetes Assoc Purified hematopoietic stem cells (HSCs) were transplanted into NOD mice to test
whether development of hyperglycemia could be prevented. Engraftment of major
histocompatibility complex-mismatched HSCs was compared with bone marrow ... Cited by 64 - Related articles - BL Direct - All 4 versions
B Nikolic, Y Takeuchi, I Leykin, Y Fudaba, RN … - Diabetes, 2004 - Am Diabetes Assoc Bone marrow transplantation from diabetes-resistant strains with complete
replacement of the recipient immune system by the allogeneic donor has led to
tolerance to donor islets and cure of diabetes in a mouse model of type 1 ... Cited by 56 - Related articles - BL Direct - All 4 versions
- ►nih.gov JA Shizuru, IL Weissman, R Kernoff, M Masek … - Proceedings of the National Academy of Sciences of …, 2000 - National Acad Sciences Engraftment of allogeneic bone marrow (BM) has been shown to induce tolerance to
organs genotypically matched with the BM donor. Immune reconstitution after BM
transplantation therefore involves re-establishment of a T cell pool ... Cited by 68 - Related articles - BL Direct - All 8 versions
- ►shouxi.net GF Beilhack, RR Landa, MA Masek, JA … - Diabetes, 2005 - Am Diabetes Assoc Progression to hyperglycemia in young nonobese diabetic (NOD) mice is blocked by
the transplantation of hematopoietic cells mismatched at the major
histocompatibility complex (MHC). Because the NOD MHC class II allele, IA ... Cited by 10 - Related articles - All 5 versions
- ►hematologylibrary.org - Free from Publisher E Seung, N Iwakoshi, BA Woda, TG Markees, … - Blood, 2000 - bloodjournal.hematologylibrary.org Recently, it has been hypothesized that procedures that induce tolerance to
hematopoietic allografts may be able to obviate any requirement for lethal
myeloablative preparation and to prevent GVHD. 1 One class of promising ... Cited by 126 - Related articles - BL Direct - All 6 versions
H Li, CL Kaufman, SS Boggs, PC Johnson, KD … - The Journal of Immunology, 1996 - Am Assoc Immnol Page 1. Mixed Allogeneic Chimerism Induced by a Sublethal Approach Prevents Autoimmune
Diabetes and Reverses lnsulitis in Nonobese Diabetic (NOD) Mice' ... Cited by 103 - Related articles - All 3 versions
CL Kaufman, H Li, ST Ildstad - The Journal of Immunology, 1997 - Am Assoc Immnol Complete replacement of the immune system via allogeneic bone marrow
transplantation ... T ype 1 diabetes is a systemic autoimmune disease of mul-
tifactorial pathogenesis in which destruction of the insu- lin-producing p ... Cited by 23 - Related articles - BL Direct - All 4 versions
JA Shizuru, L Jerabek, CT Edwards, IL … - Biology of blood and marrow transplantation: journal …, 1996 - ncbi.nlm.nih.gov Allogeneic bone marrow transplantation currently plays a critical role in the
treatment of leukemias and inherited disorders of hematopoiesis, and it shows
great promise for the treatment of numerous other diseases. The problems of ... Cited by 86 - Related articles
H Li, CL Kaufman, ST Hdstad - Surgery, 1995 - Elsevier Background. Nonobese diabetic (NOD) mice develop a systemic autoimmune disease
that resembles type I diabetes in human beings. Previous studies in NOD mice
have shown that transplantation of bone marrow from normal donors to ... Cited by 36 - Related articles - BL Direct - All 6 versions
JM Vose, PJ Bierman, JC Lynch, K Atkinson, C … - Biol Blood Marrow Transplant, 2001 - static.cjp.com INTRODUCTION Advanced-stage indolent non-Hodgkin's lymphoma (NHL) is typically
characterized by high response rates but inevitable relapse [1,2]. High-dose
chemotherapy and autol- ogous stem cell transplantation have been used ... Cited by 28 - Related articles - View as HTML - BL Direct - All 5 versions
